GLORIANA THERAPEUTICS SARL

Patent Applications and Registrations

Patent applications and USPTO patent grants for GLORIANA THERAPEUTICS SARL.The latest application filed is for "mammalian cell culture-produced neublastin antibodies".

Company Profile

7.9.8

GLORIANA THERAPEUTICS SARL - Providence MA US
GLORIANA THERAPEUTICS SARL - Geneva CH
GLORIANA THERAPEUTICS SARL - Geneve CH
GLORIANA THERAPEUTICS SARL - N/A N/A N/A

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Mammalian Cell Culture-Produced Neublastin Antibodies App 20220048984 - Gilbert; Alan ; et al.	2022-02-17
Cell Lines And Their Use In Encapsulated Cell Biodelivery App 20210128482 - KUSK; Philip ; et al.	2021-05-06
Implantable Cell Device With Supportive And Radial Diffusive Scaffolding App 20210069407 - WAHLBERG; LarsU. U. ; et al.	2021-03-11
Cell lines and their use in encapsulated cell biodelivery Grant 10,888,526 - Kusk , et al. January 12, 2	2021-01-12
Implantable cell device with supportive and radial diffusive scaffolding Grant 10,835,664 - Wahlberg , et al. November 17, 2	2020-11-17
Mammalian cell culture-produced neublastin antibodies Grant 10,717,965 - Gilbert , et al.	2020-07-21
Mammalian cell culture-produced neublastin antibodies Grant 10669523 -	2020-06-02
Mammalian Cell Culture-produced Neublastin Antibodies App 20190194602 - Gilbert; Alan ; et al.	2019-06-27
Therapeutic Protein Formulations App 20180264081 - Dimitrova; Mariana	2018-09-20
Anti-neublastin antibodies and uses thereof Grant 10,047,150 - Rossomando , et al. August 14, 2	2018-08-14
Cell Lines and Their Use in Encapsulated Cell Biodelivery App 20180177736 - Kusk; Philip ; et al.	2018-06-28
Cell lines and their use in encapsulated cell biodelivery Grant 9,884,023 - Kusk , et al. February 6, 2	2018-02-06
Implantable Cell Device with Supportive and Radial Diffusive Scaffolding App 20170232186 - Wahlberg; Lars Ulrik ; et al.	2017-08-17
Implantable cell device with supportive and radial diffusive scaffolding Grant 9,669,154 - Wahlberg , et al. June 6, 2	2017-06-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.